AAAAAA
Results:
1-25
|
Results: 25
Authors:
Kath, R
Blumenstengel, K
Fricke, HJ
Peters, HD
Hoffken, K
Citation: R. Kath et al., Bendamustine, vincristine, prednisolone in relapsed and refractory low grade non-Hodgkin's lymphoma, DEUT MED WO, 126(8), 2001, pp. 198-202
Authors:
Raida, M
Schwabe, W
Hausler, P
Van Kuilenburg, ABP
Van Gennip, AH
Behnke, D
Hoffken, K
Citation: M. Raida et al., Prevalence of a common point mutation in the Dihydropyrimidine dehydrogenase (DPD) gene within the 5 '-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls, CLIN CANC R, 7(9), 2001, pp. 2832-2839
Authors:
Wedding, U
Hoffken, K
Citation: U. Wedding et K. Hoffken, Therapy of acute myeloid leukemia in elderly patients, Z GERON GER, 34(4), 2001, pp. 269-276
Authors:
Hoffken, K
Citation: K. Hoffken, The European experience, J CL ONCOL, 19(18), 2001, pp. 112S-117S
Authors:
Grundmann, E
Hoffken, K
Citation: E. Grundmann et K. Hoffken, Prof hc Dr phil Dr med hc mult Heinz Gotze - Obituary, J CANC RES, 127(11), 2001, pp. 643-644
Authors:
Kath, R
Blumenstengel, K
Fricke, HJ
Hoffken, K
Citation: R. Kath et al., Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia, J CANC RES, 127(1), 2001, pp. 48-54
Authors:
Schiel, R
Blum, M
Muller, UA
Kohler, S
Kademann, A
Strobel, J
Hoffken, K
Citation: R. Schiel et al., Screening for people with diabetes mellitus for poor blood glucose controlin an ophthalmological laser clinic, DIABET RE C, 53(3), 2001, pp. 173-179
Authors:
Kath, R
Krack, A
Schneider, C
Katenkamp, D
Hoffken, K
Citation: R. Kath et al., A rare case of peripheral primitive neuroectodermal tumour (pPNET) with cardiac symptoms, DEUT MED WO, 125(40), 2000, pp. 1192-1194
Authors:
Ganser, A
Heil, G
Seipelt, G
Hofmann, W
Fischer, JT
Langer, W
Brockhaus, W
Kolbe, K
Ittel, H
Brack, N
Fuhr, HG
Knuth, P
Hoffken, K
Bergmann, L
Hoelzer, D
Citation: A. Ganser et al., Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML), ANN HEMATOL, 79(1), 2000, pp. 30-35
Authors:
Kath, R
Schiel, R
Muller, UA
Hoffken, K
Citation: R. Kath et al., Malignancies in patients with insulin-treated diabetes mellitus, J CANC RES, 126(7), 2000, pp. 412-417
Authors:
Clement, JH
Marr, N
Meissner, A
Schwalbe, M
Sebald, W
Kliche, KO
Hoffken, K
Wolfl, S
Citation: Jh. Clement et al., Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id geneexpression in the breast cancer cell line MCF-7, J CANC RES, 126(5), 2000, pp. 271-279
Authors:
Kath, R
Fiehler, J
Schneider, CP
Hoffken, K
Citation: R. Kath et al., Gastric cancer in very young adults: apropos four patients and a review ofthe literature, J CANC RES, 126(4), 2000, pp. 233-237
Authors:
Kath, R
Hoffken, K
Citation: R. Kath et K. Hoffken, The significance of somatostatin analogues in the antiproliferative treatment of carcinomas, REC RES CAN, 153, 2000, pp. 23-43
Authors:
Hoffken, K
Kath, R
Citation: K. Hoffken et R. Kath, The role of LH-RH analogues in the adjuvant and palliative treatment of breast cancer, REC RES CAN, 153, 2000, pp. 61-70
Authors:
Kath, R
Blumenstengel, K
Hoffken, K
Citation: R. Kath et al., Hot baths or saunas for cancer patients, DEUT MED WO, 124(10), 1999, pp. 302-302
Authors:
Hofmann, WK
Ganser, A
Seipelt, G
Ottmann, OG
Zander, C
Geissler, G
Hoffmann, K
Hoffken, K
Fischer, JT
Isele, G
Hoelzer, D
Citation: Wk. Hofmann et al., Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor, ANN HEMATOL, 78(3), 1999, pp. 125-130
Authors:
Hecker, E
Hoffken, K
Fujiki, H
Citation: E. Hecker et al., His Imperial Highness Prince Hitachi, J CANC RES, 125(3-4), 1999, pp. 121-122
Authors:
Kliche, KO
Hoffken, K
Citation: Ko. Kliche et K. Hoffken, The role of apoptosis in hematologic malignancies and modulation of apoptosis as a new therapeutic approach, J CANC RES, 125(3-4), 1999, pp. 226-231
Authors:
Sauer-Heilborn, A
Kath, R
Schneider, CP
Hoffken, K
Citation: A. Sauer-heilborn et al., Severe non-haematological toxicity after treatment with gemcitabine, J CANC RES, 125(11), 1999, pp. 637-640
Authors:
Engert, A
Hoffken, K
Freund, M
Diehl, V
Citation: A. Engert et al., Hematology and medical oncology, INTERNIST, 40(4), 1999, pp. 356-368
Authors:
Raida, M
Sarbia, M
Clement, JH
Adam, S
Gabbert, HE
Hoffken, K
Citation: M. Raida et al., Expression, regulation and clinical significance of bone morphogenetic protein 6 in esophageal squamous-cell carcinoma, INT J CANC, 83(1), 1999, pp. 38-44
Authors:
Clement, JH
Sanger, J
Hoffken, K
Citation: Jh. Clement et al., Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor, INT J CANC, 80(2), 1999, pp. 250-256
Authors:
Hoffken, K
Diehl, V
Kanz, L
Possinger, K
Zander, A
Kreienberg, R
Bender, HG
Elling, D
Jackisch, C
Luck, HJ
Mobus, V
Nitz, U
Thomssen, C
Untch, M
Gaisser, A
Citation: K. Hoffken et al., High dose treatment of mammary carcinoma. "Wait and see" is the reaction to the results of the randomized studies presented at the ASCO 1999 in Atlanta, GYNAKOLOGE, 32(8), 1999, pp. 655-655
Authors:
Sayer, HG
Kath, R
Hoffken, K
Citation: Hg. Sayer et al., High-dosage chemotherapy for solid tumors of the digestive tract, DEUT MED WO, 123(51-52), 1998, pp. 1566-1566
Authors:
Hoffken, K
Merkle, K
Schonfelder, M
Anger, G
Brandtner, M
Ridwelski, K
Seeber, S
Citation: K. Hoffken et al., Bendamustine as salvage treatment in patients with advanced progressive breast cancer: a phase II study, J CANC RES, 124(11), 1998, pp. 627-632
Risultati:
1-25
|